Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: A characterization study

Drug Design, Development and Therapy

Volumn 8, Issue , 2014, Pages 1003-1012

  Mooranian, Armin ^a   Negrulj, Rebecca ^a   Chen Tan, Nigel ^b   Al Sallami, Hesham S ^c   Fang, Zhongxiang ^b   Mukkur, Trilochan ^a   Mikov, Momir ^d,e   Golocorbin Kon, Svetlana ^d,e   Fakhoury, Marc ^f   Arfuso, Frank ^a   Al Salami, Hani ^a  

^a CURTIN UNIVERSITY   (Australia)

^b CURTIN UNIVERSITY   (Australia)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d UNIVERSITY OF NOVI SAD   (Serbia)

^e UNIVERSITY OF MONTENEGRO   (Montenegro)

^f UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Bile acids; Diabetes; Gliclazide; Polymer; Type

Indexed keywords

ALGINIC ACID; DEOXYCHOLIC ACID; GLICLAZIDE; ANTIDIABETIC AGENT; EXCIPIENT; GLUCURONIC ACID; HEXURONIC ACID; MICROCAPSULE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL CELL; CONTROLLED STUDY; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DETERMINATION; ENERGY DISPERSIVE X RAY SPECTROMETRY; EXCIPIENT COMPATIBILITY; INFRARED SPECTROSCOPY; MICROENCAPSULATION; NONHUMAN; PROCESS OPTIMIZATION; RAT; SCANNING ELECTRON MICROSCOPY; SHEAR RATE; SHEAR STRESS; STRUCTURE ANALYSIS; TEMPERATURE MEASUREMENT; THERMAL ANALYSIS; THERMOSTABILITY; TORQUE; X RAY SPECTROMETRY; ANIMAL; CHEMISTRY; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; FLOW KINETICS; MEDICINAL CHEMISTRY; MICROCAPSULE; PARTICLE SIZE;

ALGINATES; ANIMALS; ARTIFICIAL CELLS; CAPSULES; CHEMISTRY, PHARMACEUTICAL; DEOXYCHOLIC ACID; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; EXCIPIENTS; GLICLAZIDE; GLUCURONIC ACID; HEXURONIC ACIDS; HYPOGLYCEMIC AGENTS; PARTICLE SIZE; RATS; RHEOLOGY;

EID: 84905244183     PISSN: None     EISSN: 11778881     Source Type: Journal    
DOI: 10.2147/DDDT.S65396     Document Type: Article

References (43)

1. Barbeau WE, Bassaganya-Riera J, Hontecillas R. Putting the pieces of the puzzle together-a series of hypotheses on the etiology and pathogenesis of type1diabetes. Med Hypotheses. 2007; 68: 607-619.
2. Ferrannini E. Insulin resistance versus insulin deficiency in non-insulindependent diabetes mellitus: problems and prospects. Endocr Rev. 1998; 19: 477-490.
3. Oh DY, Olefsky JM. Omega3fatty acids and GPR120. Cell Metab. 2012; 15: 564-565.
4. Burns RN, Moniri NH. Agonism with the omega-3 fatty acids alphalinolenic acid and docosahexaenoic acid mediates phosphorylation of both the short and long isoforms of the human GPR120 receptor. Biochem Biophys Res Commun. 2010; 396: 1030-1035.
5. Al-Salami H, Butt G, Tucker I, Skrbic R, Golocorbin-Kon S, Mikov M. Probiotic treatment proceeded by a single dose of bile acid and gliclazide exert the most hypoglycemic effect in Type1diabetic rats. Medical Hypothesis Research. 2008; 4: 93-101.
6. Taylor AR, Brownsill RD, Grandon H, et al. Pharmacokinetics and pharmacodynamics of gliclazide in Caucasians and Australian Aborigines with type2 diabetes. Br J Clin Pharmacol. 2000; 49: 223-230.
7. Al-Salami H, Butt G, Tucker I, Mikov M. Influence of the semisynthetic bile acid MKC on the ileal permeation of gliclazide in vitro in healthy and diabetic rats treated with probiotics. Methods Find Exp Clin Pharmacol. 2008; 30: 107-113.
8. Lalić-Popović M, VasovićV, Milijašević B, Goločorbin-Kon S, Al-Salami H, Mikov M. Deoxycholic acid as a modifier of the permeation of gliclazide through the blood brain barrier of a rat. J Diabetes Res. 2013; 2013: 598603.
9. Houten SM, Watanabe M, Auwerx J. Endocrine functions of bile acids. EMBO J. 2006; 25: 1419-1425.
10. Negrulj R, Mooranian A, Al-Salami H. Potentials and limitations of bile acids in type2diabetes mellitus: applications of microencapsulation as a novel oral delivery system. Journal of Endocrinology and Diabetes Mellitus. 2013; 1: 49-59.
11. Mikov M, Al-Salami H, Golocorbin-Kon S, Skrbic R, Raskovic A, Fawcett JP. The influence of3alpha, 7alpha-dihydroxy-12-keto-5betacholanate on gliclazide pharmacokinetics and glucose levels in a rat model of diabetes. Eur J Drug Metab Pharmacokinet. 2008; 33: 137-142.
12. Efentakis M, Buckton G. The effect of erosion and swelling on the dissolution of theophylline from low and high viscosity sodium alginate matrices. Pharm Dev Technol. 2002; 7: 69-77.
13. Al-Kassas RS, Al-Gohary OM, Al-Faadhel MM. Controlling of systemic absorption of gliclazide through incorporation into alginate beads. Int J Pharm. 2007; 341: 230-237.
14. Takka S, Acartürk F. Calcium alginate microparticles for oral administration: I: Effect of sodium alginate type on drug release and drug entrapment efficiency. J Microencapsul. 1999; 16: 275-290.
15. Fakhoury M, Coussa-Charley M, Al-Salami H, Kahouli I, Prakash S. Use of artificial cell microcapsule containing thalidomide for treating TNBS-induced Crohn's disease in mice. Curr Drug Deliv. 2014; 11: 146-153.
16. Al-Salami H, Butt G, Tucker I, et al. Gliclazide reduces MKC intestinal transport in healthy but not diabetic rats. Eur J Drug Metab Pharmacokinet. 2009; 34: 43-50.
17. Al-Salami H, Butt G, Tucker I, Mikov M. Influence of the semisynthetic bile acid (MKC) on the ileal permeation of gliclazide in healthy and diabetic rats. Methods Find Exp Clin Pharmacol. 2008; 30: 107-113.
18. Mooranian A, Negrulj R, Mathavan S, et al. A complex microencapsulated system: a platform for optimised oral delivery of antidiabetic drug-bile acid formulations. Pharm Dev Technol. In press2014.
19. Mikov M, Al-Salami H, Kuhajda K, Kevresan S, Golocorbin-Kon S, Fawcett JP. Pharmacokinetics and hypoglycemic activity of the semisynthetic bile acid salt, sodium 3a, 7o-dihydroxy-12-oxo-5j3-cholanate in diabetic rats. FEBS Congress, Istanbul, June 2006. The FEBS Journal. 2006; 273 (Suppl 1): 210.
20. Pal D, Nayak AK. Development, optimization, and anti-diabetic activity of gliclazide-loaded alginate-methyl cellulose mucoadhesive microcapsules. AAPS PharmSciTech. 2011; 12: 1431-1441.
21. Prajapati S, Tripathi P, Ubaidulla U, Anand V. Design and development of gliclazide mucoadhesive microcapsules: in vitro and in vivo evaluation. AAPS PharmSciTech. 2008; 9: 224-230.
22. Yang Y, Campanella OH, Hamaker BR, Zhang G, Gu Z. Rheological investigation of alginate chain interactions induced by concentrating calcium cations. Food Hydrocoll. 2013; 30: 26-32.
23. Barakat NS, Shazly GA, Almedany AH. Influence of polymer blends on the characterization of gliclazide-encapsulated into poly (ε-caprolactone) microparticles. Drug Dev Ind Pharm. 2013; 39: 352-362.
24. de Celis Alonso B, Rayment P, Ciampi E, et al. NMR relaxometry and rheology of ionic and acid alginate gels. Carbohydr Polym. 2010; 82: 663-669.
25. Draget KI, Taylor C. Chemical, physical and biological properties of alginates and their biomedical implications. Food Hydrocoll. 2011; 25: 251-256.
26. Bonino CA, Samorezov JE, Jeon O, Alsberg E, Khan SA. Real-time in situ rheology of alginate hydrogel photocrosslinking. Soft Matter. 2011; 7: 11510-11517.
27. Pamies R, Rodríguez Schmidt R, López Martínez MC, García de la Torre J. The influence of mono and divalent cations on dilute and non-dilute aqueous solutions of sodium alginates. Carbohydr Polym. 2010; 80: 248-253.
28. Legrand J, Dumont E, Comiti J, Fayolle F. Diffusion coefficients of ferricyanide ions in polymeric solutions-comparison of different experimental methods. Electrochim Acta. 2000; 45: 1791-1803.
29. Desai SR, Dharwadkar SR. Study of polymorphic transformation of ornidazole drug by differential scanning calorimetry and other complementary techniques. Acta Pol Pharm. 2008; 65: 409-413.
30. Gill P, Moghadam TT, Ranjbar B. Differential scanning calorimetry techniques: applications in biology and nanoscience. J Biomol Tech. 2010; 21: 167-193.
31. Al-Salami H, Butt G, Fawcett JP, Tucker IG, Golocorbin-Kon S, Mikov M. Probiotic treatment reduces blood glucose levels and increases systemic absorption of gliclazide in diabetic rats. Eur J Drug Metab Pharmacokinet. 2008; 33: 101-106.
32. Kulkarni AR, Soppimath KS, Aminabhavi TM, Rudzinski WE. In-vitro release kinetics of cefadroxil-loaded sodium alginate interpenetrating network beads. Eur J Pharm Biopharm. 2001; 51: 127-133.
33. Sarmento B, Ferreira D, Veiga F, Ribeiro A. Characterization of insulinloaded alginate nanoparticles produced by ionotropic pre-gelation through DSC and FTIR studies. Carbohydr Polym. 2006; 66: 1-7.
34. Takka S, Cali AG. Bile salt-reinforced alginate-chitosan beads. Pharm Dev Technol. 2012; 17: 23-29.
35. Barakat NS, Almurshedi AS. Design and development of gliclazide-loaded chitosan microparticles for oral sustained drug delivery: in-vitro/in-vivo evaluation. J Pharm Pharmacol. 2011; 63: 169-178.
36. Thybo P, Pedersen BL, Hovgaard L, Holm R, Mullertz A. Characterization and physical stability of spray dried solid dispersions of probucol and PVP-K30. Pharm Dev Technol. 2008; 13: 375-386.
37. Ajun W, Yan S, Li G, Huili L. Preparation of aspirin and probucol in combination loaded chitosan nanoparticles and in vitro release study. Carbohydr Polym. 2009; 75: 566-574.
38. Bakatselou V, Oppenheim RC, Dressman JB. Solubilization and wetting effects of bile salts on the dissolution of steroids. Pharm Res. 1991; 8: 1461-1469.
39. Martoni C, Bhathena J, Urbanska AM, Prakash S. Microencapsulated bile salt hydrolase producing Lactobacillus reuteri for oral targeted delivery in the gastrointestinal tract. Appl Microbiol Biotechnol. 2008; 81: 225-233.
40. Al-Salami H, Butt G, Tucker I, Skrbic R, Golocorbin-Kon S, Mikov M. Probiotic pre-treatment reduces gliclazide permeation (ex vivo) in healthy rats but increases it in diabetic rats to the level seen in untreated healthy rats. Arch Drug Inf. 2008; 1: 35-41.
41. Yang L, Xu Y, Su Y, et al. FT-IR spectroscopic study on the variations of molecular structures of some carboxyl acids induced by free electron laser. Spectrochim Acta A Mol Biomol Spectrosc. 2005; 62: 1209-1215.
42. Daemi H, Barikani M. Synthesis and characterization of calcium alginate nanoparticles, sodium homopolymannuronate salt and its calcium nanoparticles. Scientia Iranica, 2012; 19(6): 2023-2028.
43. Devi MP, Sekar M, Chamundeswari M, et al. A novel wound dressing material-fibrin-chitosan-sodium alginate composite sheet. Bulletin of Materials Science. 2012; 35: 1157-1163.